- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07855042
A Multiphase Analysis of Next-generation Trail Footwear (NEXTGENTRAIL)
A Multiphase Analysis of Next-generation Trail Footwear: Optimising Advanced Footwear Technology From Laboratory Outcomes to Field-based Running Performance
This study will investigate how different advanced-foam trail-running footwear configurations affect running economy, performance, comfort, and fatigue in competitive trail runners. The project aims to determine whether footwear characteristics, particularly foam properties and stack height, influence physiological and biomechanical responses during both controlled laboratory running and real-world trail running.
Approximately 30 competitive trail runners with experience in technical trail running and no musculoskeletal injury during the previous six months will participate. The study will use a two-phase experimental design.
In Phase 1, participants will complete running economy assessments in three footwear conditions in randomized order. The footwear conditions will include a high-stack advanced-foam prototype, a medium-stack advanced-foam prototype, and a conventional-foam shoe. Laboratory testing will be performed during uphill and downhill treadmill running. Participants will also complete field-based running economy trials on real trail terrain at a controlled speed, followed by a short time trial to establish a representative running pace.
In Phase 2, participants will complete prolonged trail-running sessions in the two advanced-foam footwear configurations on a 15-km trail course. Running economy and fatigue-related responses will be assessed repeatedly during the prolonged exercise sessions to evaluate changes in physiological and biomechanical efficiency over time.
The primary physiological outcome will be running economy, assessed through oxygen consumption and energy cost. Additional outcomes will include heart rate, step frequency, step length, ground contact time, perceived exertion, comfort, perceived performance, and pacing-related measures.
The study will compare laboratory and field responses to determine whether differences in running economy observed under controlled conditions are maintained during real trail running and whether footwear configuration influences the deterioration of running economy and fatigue during prolonged exercise.
Visão geral do estudo
Status
Intervenção / Tratamento
Descrição detalhada
Trail running involves substantial variations in terrain, gradient, and surface characteristics, creating physiological and biomechanical demands that differ from road running. Footwear may influence these responses through characteristics such as midsole foam properties, cushioning, and stack height. However, evidence regarding advanced footwear technology in trail running remains limited, particularly regarding whether laboratory findings translate to real-world trail conditions and whether footwear characteristics influence the maintenance of running performance during prolonged exercise.
The objective of this study is to investigate the effects of different advanced-foam trail-running footwear configurations on running economy, performance, comfort, biomechanical responses, and fatigue under laboratory and field-based trail-running conditions. The study will also examine whether footwear configuration influences durability, defined in this project as the maintenance of running economy and physiological efficiency during prolonged exercise.
The study will recruit approximately 30 competitive trail runners with experience in technical trail running who have been free from musculoskeletal injury for at least six months. Written informed consent will be obtained from all participants.
The study will use a two-phase experimental design.
In Phase 1, participants will be evaluated under three footwear conditions in randomized order:
- High-stack advanced-foam shoe prototype: approximately 38.5 mm stack height, 6-mm drop, and 220 g.
- Medium-stack advanced-foam shoe prototype: approximately 28.5 mm stack height, 6-mm drop, and 180 g.
- Conventional-foam footwear: approximately 31.5 mm stack height, 6-mm drop, and 300 g.
If necessary, shoe mass will be standardized by adding weight to the lighter footwear configurations to help isolate the effects of foam characteristics.
Laboratory running economy will be assessed using 5-minute running trials under uphill and downhill conditions. Uphill running will be performed at 8 km/h with a 6% positive slope, and downhill running at 16 km/h with a 6% negative slope. Oxygen uptake and carbon dioxide output will be measured breath-by-breath using a metabolic gas analysis system. Biomechanical variables will also be recorded, including step frequency and ground contact time.
Following the laboratory assessment, participants will complete field-based running economy trials on a real trail surface. Each footwear condition will be tested in randomized order during 5-minute running trials at a controlled speed of 12 km/h. Speed will be controlled using acoustic signals. Oxygen consumption and carbon dioxide production will be measured using a portable metabolic system, while spatiotemporal gait variables will be recorded using an inertial measurement device. Participants will subsequently complete a short time trial to establish a representative running pace for the subsequent durability assessment.
In Phase 2, participants will complete prolonged trail-running sessions using the two advanced-foam footwear configurations. Each footwear condition will be assessed during a separate visit. The sessions will consist of repeated running on a 15-km trail course comprising five 3-km loops and approximately 375 m of elevation gain. Running intensity will be based on the pace obtained during the Phase 1 time trial, according to the final study protocol.
Running economy will be assessed repeatedly during the prolonged exercise sessions using portable metabolic measurements. Changes in physiological efficiency and fatigue will be evaluated across the running session. GPS-based measurements will also be collected to monitor pacing and changes in running performance.
The main physiological outcome is running economy, assessed through oxygen consumption and energy cost relative to running speed. Additional physiological, biomechanical, and perceptual outcomes include heart rate, step frequency, step length, ground contact time, rating of perceived exertion, perceived comfort, perceived performance, and pacing-related measures.
The study is designed to determine whether footwear-related differences in running economy identified under controlled laboratory conditions are maintained during real-world trail running. It will also investigate whether advanced-foam footwear configurations influence the deterioration of running economy and fatigue during prolonged trail-running exercise. The findings are intended to contribute to the scientific understanding of interactions between trail-running footwear, biomechanics, physiological responses, and endurance performance.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Fernando González-Mohíno, PhD
- Número de telefone: +34 690216354
- E-mail: fernando.gmayoralas@uclm.es
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Competitive trail runners.
- Experience in technical trail running.
- Willingness to provide written informed consent.
Exclusion Criteria:
- Musculoskeletal injury in the previous 6 months.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição cruzada
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: High-Stack Advanced-Foam Footwear
Participants will perform the experimental running trials wearing a high-stack advanced-foam trail-running shoe (approximately 38.5 mm stack height, 6 mm drop, and 220 g). This footwear condition will be used to assess running economy, physiological and biomechanical responses, comfort, perceived performance, and fatigue-related changes during laboratory and field-based trail running. |
Three trail running shoes with different characteristics will be compared in terms of their physiological and biomechanical effects. |
|
Experimental: Medium-Stack Advanced-Foam Footwear
Participants will perform the experimental running trials wearing a medium-stack advanced-foam trail-running shoe (approximately 28.5 mm stack height, 6 mm drop, and 180 g). This footwear condition will be used to assess running economy, physiological and biomechanical responses, comfort, perceived performance, and fatigue-related changes during laboratory and field-based trail running. |
Three trail running shoes with different characteristics will be compared in terms of their physiological and biomechanical effects. |
|
Comparador Ativo: Conventional-Foam Footwear
Participants will perform the experimental running trials wearing a conventional-foam trail-running shoe (approximately 31.5 mm stack height, 6 mm drop, and 300 g). This footwear condition will serve as the conventional-footwear comparison for assessing running economy, physiological and biomechanical responses, comfort, perceived performance, and fatigue-related changes during laboratory and field-based trail running. |
Three trail running shoes with different characteristics will be compared in terms of their physiological and biomechanical effects. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Running economy
Prazo: During each 5-minute running trial for each footwear model in Phase 1 (indoor laboratory conditions) and Phase 2 (outdoor trail-running conditions).
|
Running economy will be assessed through oxygen consumption (V̇O₂) and energy cost expressed in W·kg-¹ during running in the different footwear conditions. Measurements will be obtained using breath-by-breath gas analysis during controlled laboratory and field-based trail-running trials. |
During each 5-minute running trial for each footwear model in Phase 1 (indoor laboratory conditions) and Phase 2 (outdoor trail-running conditions).
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Heart Rate
Prazo: During each 5-minute running trial for each footwear model in Phase 1 (indoor laboratory conditions) and Phase 2 (outdoor trail-running conditions).
|
Continuous heart rate will be recorded during the running trials to characterize the physiological response to each footwear condition. |
During each 5-minute running trial for each footwear model in Phase 1 (indoor laboratory conditions) and Phase 2 (outdoor trail-running conditions).
|
|
Spatiotemporal Gait Parameters
Prazo: During each 5-minute running trial for each footwear model in Phase 1 (indoor laboratory conditions) and Phase 2 (outdoor trail-running conditions).
|
Biomechanical responses will be assessed through step frequency (steps/min), step length (m), and ground contact time (ms) during running in the different footwear conditions. |
During each 5-minute running trial for each footwear model in Phase 1 (indoor laboratory conditions) and Phase 2 (outdoor trail-running conditions).
|
|
Comfort, Perceived Performance, and Rate of Perceived Exertion
Prazo: After each 5-minute running trial for each footwear model in Phase 1 (indoor laboratory conditions) and Phase 2 (outdoor trail-running conditions).
|
Participants' subjective perceptions of footwear comfort, perceived performance, and rate of perceived exertion will be assessed during the experimental running conditions. |
After each 5-minute running trial for each footwear model in Phase 1 (indoor laboratory conditions) and Phase 2 (outdoor trail-running conditions).
|
Colaboradores e Investigadores
Patrocinador
Publicações e links úteis
Publicações Gerais
- Rodrigo-Carranza V, Hoogkamer W, Salinero JJ, Rodriguez-Barbero S, Gonzalez-Rave JM, Gonzalez-Mohino F. Influence of Running Shoe Longitudinal Bending Stiffness on Running Economy and Performance in Trained and National Level Runners. Med Sci Sports Exerc. 2023 Dec 1;55(12):2290-2298. doi: 10.1249/MSS.0000000000003254. Epub 2023 Jul 14.
- Rodrigo-Carranza V, Hoogkamer W, Gonzalez-Rave JM, Gonzalez-Mohino F. Relationship Between Advanced Footwear Technology Longitudinal Bending Stiffness and Energy Cost of Running. Scand J Med Sci Sports. 2024 Jun;34(6):e14687. doi: 10.1111/sms.14687.
- Rodrigo-Carranza V, Gonzalez-Mohino F, Santos-Concejero J, Gonzalez-Rave JM. Influence of Shoe Mass on Performance and Running Economy in Trained Runners. Front Physiol. 2020 Sep 23;11:573660. doi: 10.3389/fphys.2020.573660. eCollection 2020.
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Outros números de identificação do estudo
- CEIS-2026-174642
- PID2025-170911NB-I00 (Número de outro subsídio/financiamento: Agencia Estatal de Investigación. Ministerio de Ciencia, Innovación y Universidades)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
The investigators have not yet decided whether individual participant data (IPD) will be shared. A decision regarding IPD sharing will be made after completion of the study, taking into consideration ethical, legal, privacy, and data protection requirements.
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .